Research progress of traditional Chinese medicine in the treatment of endocrine metabolic diseases in 2023

This study aimed to provide a comprehensive review of the research progress in Chinese medicine in the treatment of endocrine metabolic diseases in 2023, covering traditional Chinese medicine (TCM) monomers, TCM extracts, and TCM combinations, including non-alcoholic fatty liver disease, type 2 diabetes mellitus and its complications, obesity, hyperuricaemia, and thyroid disorders. After systematic sorting and summary, we found that in 2023, the research focusing on the application of TCM for endocrine metabolic diseases was still on the mechanism of action at the cellular and molecular levels, which not only influenced the classical pathways of lipid metabolism, but also delved into the key mechanisms of anti-inflammation, anti-oxidation, anti-insulin resistance, and so on. Additionally, TCM has shown remarkable results in the treatment of endocrine metabolic diseases by improving intestinal flora disorders and abnormal cellular iron death. These research results provide valuable ideas, methods, and tools for TCM in the prevention and treatment of endocrine metabolic diseases, and provide important references and guidance for future research and practice.